Overview

Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes

Status:
Completed

Trial end date:
2014-09-04

Target enrollment:

Participant gender:

Summary

This trial is conducted in Africa and Asia. The aim of the trial is to investigate the efficacy and safety of liraglutide versus sulphonylurea (SU) both in combination with metformin during Ramadan in subjects with type 2 diabetes (T2DM).

Phase:

Phase 4

Details

Lead Sponsor:

Novo Nordisk A/S

Treatments:

Liraglutide
Metformin